Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulatory T cells (Tregs) are a specialized subpopulation of CD4+ lymphocytes that play a critical role in modulating the immune system. Their primary function is to maintain immune homeostasis and self-tolerance by suppressing excessive or misdirected immune responses, thereby preventing autoimmune diseases and limiting chronic inflammation. Tregs are characterized by the expression of CD25 and the transcription factor FOXP3. They can be either natural (nTregs) developing in the thymus or induced (iTregs) differentiating in the periphery. Tregs exert their suppressive functions through various mechanisms, including cytokine secretion (IL-10, TGF-β), CTLA-4 mediated downregulation of costimulatory molecules, IL-2 deprivation, and adenosine production. Tregs play a significant role in autoimmune disease prevention, cancer progression/modulation, and transplant/fetal tolerance.
Immunosuppression via cytokine secretion (IL-10, TGF-β), CTLA-4 mediated downregulation of costimulatory molecules, IL-2 deprivation, adenosine production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-regulatory Lymphocyte (Treg).